Showing 1 - 10 of 11 Heart Failure

Status: Open Not Enrolling

Investigator: Dipan Shah

Study Coordinator: Bevin Lopez

Phone: 346.238.5810

This study is designed to evaluate the efficacy of Dotarem enhanced MRI compared to Magnevist and Gadavist enhanced MRI in identifying myocardial infarct. Eighty patients will be recruited for this study. Patients with known CAD and undergoing c ... Read more >

Status: Open Not Enrolling

Investigator: Neal Kleiman

Study Coordinator: Deena Victor

Phone: 713.441.4536

Brief Summary: To evaluate safety and effectiveness of the ACURATE Transfemoral Aortic Valve System for transcatheter aortic valve replacement (TAVR) in subjects with severe native aortic stenosis who are indicated for TAVR. Detailed Descripti ... Read more >

Status: Enrolling

Investigator: Marvin Atkins

Study Coordinator: Padmaja Naik

Phone: 713.441.7386

The purpose of this study is to characterize the safety and effectiveness of the Medtronic Avalus Ultra aortic valve bioprosthesis in patients with aortic valve disease. ... Read more >

Status: Enrolling

Investigator: Sachin Goel

Study Coordinator: Deena Victor

Phone: 713.441.4536

Brief Summary: The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral regurgitation = Grade III in whom transcatheter therapy i ... Read more >

Status: Enrolling

Investigator: Sachin Goel

Study Coordinator: Tia McGaughy

Phone: 346.238.4576

The objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treating patients with symptomatic, severe native aortic stenosis who are considered intermediate or l ... Read more >

Status: Enrolling

Investigator: Neal Kleiman

Study Coordinator: Deena Victor

Phone: 713.441.4536

Brief Summary: Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, symptomatic AS. Detailed Description: Multi-center, international, prospective, randomized ... Read more >

Status: Open Not Enrolling

Investigator: Sherif Nagueh

Study Coordinator: Sohaib Mhaidi

Phone: 346.238.6402

Hypertrophic cardiomyopathy (HCM) is the most common monogenic heart disease and the most frequent cause of sudden cardiac death (SCD) in the young. It is characterized by unexplained left ventricular hypertrophy (LVH), diffuse and patchy fibros ... Read more >

Status: Enrolling

Investigator: Neal Kleiman

Study Coordinator: Padmaja Naik

Phone: 713.441.7386

The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart p ... Read more >

Status: Enrolling

Investigator: Alpesh Shah

Study Coordinator: Padmaja Naik

Phone: 713.441.7386

The purpose of this single-arm interventional study is to evaluate the long-term safety, efficacy, and durability of the Symplicity Spyral system in subjects treated with renal denervation. Additionally, long-term follow-up data will also be ... Read more >

Status: Open Not Enrolling

Investigator: Maham Rahimi

Study Coordinator: Sohaib Mhaidi

Phone: 346.238.6402

This is a multi-surgeon monocentric study at Houston Methodist Hospital (HMH) to decrease the number of groin wound complications using BIASURGE Advanced Surgical Solution (BIASURGE) after common femoral artery exposure for vascular surgery proc ... Read more >

Status: Enrolling

Investigator: Sachin Goel

Study Coordinator: Tia McGaughy

Phone: 346.238.4576

Brief Summary: The objective of this early feasibility study is to gain early clinical insight into the performance of the Intrepid transcatheter tricuspid valve replacement (TTVR) system intended for transfemoral access to deliver a self-expan ... Read more >